Stock price when the opinion was issued
Bumpy. Q2 is a crucial selling season for them, and supply/demand dynamics in potash will be key. Reintroduced it to portfolios in January this year. Fertilizer cycle has bottomed and is slowly turning up. Vertically integrated with downstream farm supply stores. Operational improvement in South America to improve margins.
Trading at half of peak value of 3 years ago. Lots of upside.
Likes it, as well as its US counterpart MOS. Part of his bias toward commodities. Downtrend ended, rounded bottom, now forming a neckline. Trying to break out; hasn't yet, but chart and fundamentals are set up to do so. Could get quite a bit higher, but you have to be patient (it's a commodity, and there's a cycle at work).
World's largest crop nutrient business. Upstream production vertically integrated with downstream stores (in US, Canada, and some in South America). Commodity prices for the 3 fertilizer ingredients has bottomed, supported by steadily improving prices for major cash crops (corn, wheat, soybeans).
Trades roughly at long-term average multiple. Earnings on cusp of a turning point. Dividend's increased 36% since merger in 2018, plus reduced outstanding shares by 23% since then. Yield 3.6%.
Lots of geopolitical things happening. When stock shot up from Russian invasion, sold some but still retains a 1/2-2/3 position. Likes it long term. BHP is bringing on Jansen, but it's behind (and second phase may be mothballed). Good diversifier. Nice yield.
For new clients, buying a half position. Ideally, want to buy under $70.
Choppy stock, pretty volatile. But you can see the nice uptrend on the chart, which helps you digest the highs and lows. After a big downtrend, you had basing, and then a nascent uptrend -- stock's looking through bad news, just be patient. Can still buy today and do well.
NTR mentioned it is turning to AI, and more so automation, to help with increased efficiency and reduce workplace injuries for its employees, and that it will spend $15 to $20 million per year over the next 10 years to make this a reality. We feel the market mostly ignored this as it seems to be more of the use of 'automation' rather than brand new AI tech, and for now the improved efficiencies are not quantified but the annual investment cost has been quantified by the company.
The company is still in the bottoming process from its large decline over the past couple of years, and we would be OK slowly accumulating a position here, and seeing if price can hold in this mid-$60s range.
Unlock Premium - Try 5i Free